Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

OBJECTIVES: Biological therapy represents important advances in alleviating rheumatoid arthritis (RA), but the effect on interstitial lung disease (ILD) has been controversial. The objective of this study was to assess the risk of such treatment for patients with ILD. DESIGN: Case–control cohorts. S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Nakashita, Tamao, Ando, Katsutoshi, Kaneko, Norihiro, Takahashi, Kazuhisa, Motojima, Shinji
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2014
Matèries:
Respiratory Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139628/
https://ncbi.nlm.nih.gov/pubmed/25125479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005615
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars